Sunny Pharmtech Statistics

Total Valuation

Sunny Pharmtech has a market cap or net worth of TWD 3.07 billion. The enterprise value is 3.25 billion.

Market Cap	3.07B
Enterprise Value	3.25B

Important Dates

The next estimated earnings date is Wednesday, April 9, 2025.

Earnings Date	Apr 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Sunny Pharmtech has 148.76 million shares outstanding. The number of shares has increased by 6.71% in one year.

Current Share Class	n/a
Shares Outstanding	148.76M
Shares Change (YoY)	+6.71%
Shares Change (QoQ)	+1.20%
Owned by Insiders (%)	17.79%
Owned by Institutions (%)	3.56%
Float	105.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.29
PB Ratio	2.64
P/TBV Ratio	2.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 59.79, with an EV/FCF ratio of -29.39.

EV / Earnings	-64.31
EV / Sales	6.69
EV / EBITDA	59.79
EV / EBIT	n/a
EV / FCF	-29.39

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.34.

Current Ratio	3.24
Quick Ratio	2.32
Debt / Equity	0.34
Debt / EBITDA	7.29
Debt / FCF	-3.58
Interest Coverage	-7.14

Financial Efficiency

Return on equity (ROE) is -4.83% and return on invested capital (ROIC) is -2.73%.

Return on Equity (ROE)	-4.83%
Return on Assets (ROA)	-2.55%
Return on Invested Capital (ROIC)	-2.73%
Return on Capital Employed (ROCE)	-4.41%
Revenue Per Employee	3.37M
Profits Per Employee	-350,542
Employee Count	138
Asset Turnover	0.29
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.07% in the last 52 weeks. The beta is 0.03, so Sunny Pharmtech's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-36.07%
50-Day Moving Average	21.54
200-Day Moving Average	24.32
Relative Strength Index (RSI)	45.82
Average Volume (20 Days)	132,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunny Pharmtech had revenue of TWD 485.01 million and -50.48 million in losses. Loss per share was -0.34.

Revenue	485.01M
Gross Profit	281.20M
Operating Income	-67.47M
Pretax Income	-50.48M
Net Income	-50.48M
EBITDA	49.37M
EBIT	-67.47M
Loss Per Share	-0.34

Full Income Statement

Balance Sheet

The company has 221.23 million in cash and 395.71 million in debt, giving a net cash position of -174.48 million or -1.17 per share.

Cash & Cash Equivalents	221.23M
Total Debt	395.71M
Net Cash	-174.48M
Net Cash Per Share	-1.17
Equity (Book Value)	1.16B
Book Value Per Share	7.81
Working Capital	300.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.18 million and capital expenditures -99.27 million, giving a free cash flow of -110.45 million.

Operating Cash Flow	-11.18M
Capital Expenditures	-99.27M
Free Cash Flow	-110.45M
FCF Per Share	-0.74

Full Cash Flow Statement

Margins

Gross margin is 57.98%, with operating and profit margins of -13.91% and -10.41%.

Gross Margin	57.98%
Operating Margin	-13.91%
Pretax Margin	-10.41%
Profit Margin	-10.41%
EBITDA Margin	10.18%
EBIT Margin	-13.91%
FCF Margin	n/a

Dividends & Yields

Sunny Pharmtech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.71%
Shareholder Yield	-6.71%
Earnings Yield	-1.64%
FCF Yield	-3.60%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sunny Pharmtech has an Altman Z-Score of 5.89.

Altman Z-Score	5.89
Piotroski F-Score	n/a